Forgot password?
Sign up today and your first download is free.
REGISTER
Australia's ambassador to the United States has made clear to the U.S. government and business groups that demanding commitments beyond those reflected in the text of the Trans-Pacific Partnership is a nonstarter, regardless of the form they would take.
The fight over the period of market exclusivity for biologics under the Trans-Pacific Partnership has become a point of controversy in Australia's federal election slated for July, with the opposition Labor Party charging that the current government seeking reelection will concede to further changes to the marketing exclusivity period for biologics with the effect of driving up drug prices.
Critics are incorrectly framing the Trans-Pacific Partnership's final outcomes on biologics and patent term extension by focusing their complaints on what is required by the agreement as opposed to what actually occurs on the ground in TPP countries, New Zealand's Ambassador to the U.S and former Trade Minister Tim Groser said on May 13.
New Zealand's Parliament on May 12 narrowly approved the first of three readings of a bill to implement its Trans-Pacific Partnership obligations in a 62 to 59 vote.